Use of botulinum toxin type B for the treatment of detrusor hyperreflexia in a patient with multiple sclerosis: a case report.

Author: DykstraDennis D, GoldishGary, PryorJon

Paper Details 
Original Abstract of the Article :
We describe a patient with multiple sclerosis (MS) who had detrusor hyperreflexia that was not responsive to oral medications or clean intermittent catheterization. This patient was successfully treated with 2 separate injections of botulinum toxin type B into the bladder. The results of the treatme...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/s0003-9993(03)00202-8

データ提供:米国国立医学図書館(NLM)

Botulinum Toxin: A Beacon of Hope for Detrusor Hyperreflexia in Multiple Sclerosis

Multiple sclerosis (MS) is a chronic neurological disorder that can affect various bodily functions, including bladder control. Detrusor hyperreflexia, a condition characterized by involuntary bladder contractions, can be a significant challenge for individuals with MS. This case report explores the potential of botulinum toxin type B for treating detrusor hyperreflexia in a patient with MS. Think of it like discovering a hidden oasis in the desert: a source of relief and potential for improvement.

Botulinum Toxin: A Novel Approach for Detrusor Hyperreflexia in MS

This case report demonstrates the effectiveness of botulinum toxin type B in treating detrusor hyperreflexia in a patient with MS, offering a potential new treatment option. It's like finding a new path through a vast desert: a beacon of hope for individuals struggling with bladder control issues related to MS.

Managing Detrusor Hyperreflexia: A Journey Towards Better Bladder Control

This research highlights the potential benefits of botulinum toxin type B for individuals with MS experiencing detrusor hyperreflexia. It's like creating a more sustainable oasis in the desert: improving bladder control and enhancing quality of life. It underscores the importance of exploring innovative treatments to address the multifaceted challenges of MS.

Dr.Camel's Conclusion

This case report provides a compelling example of the potential benefits of botulinum toxin type B for treating detrusor hyperreflexia in individuals with MS. Further research is needed to fully understand the efficacy and safety of this approach, but it offers a ray of hope for improving bladder control and quality of life for individuals living with MS.

Date :
  1. Date Completed 2003-10-23
  2. Date Revised 2019-09-01
Further Info :

Pubmed ID

13680581

DOI: Digital Object Identifier

10.1016/s0003-9993(03)00202-8

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.